Back to discover
Disease
Psychomotor Agitation
Late-stage therapeutic developmentEmerging research
1
Publications
8
Clinical trials
2021
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
New approaches to symptomatic treatments for Alzheimer's disease.
Research2021-01-13Molecular neurodegeneration
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Executive briefingUpdating summary…Momentum: Low
Key developments
- 1 clinical trial with recent milestones (1 completed or reporting results).
Clinical MilestonesViewHide
Recently completed
Activity timeline1
- 2025-10-07ClinicalAssessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar DisorderCompleted
Clinical trials
The current development programme across all trial phases.
Clinical programme
8
0
4
6
Late-stage studies
Recently completed
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Recent publications
Leading journals1
- Molecular neurodegeneration1
Leading researchers1
- Cummings J1
Affiliations (unnormalised)1
- Chambers-Grundy Center for Transformative Neuroscience1
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
A feeling of restlessness associated with increased motor activity. This may occur as a manifestation of nervous system drug toxicity or other conditions.
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.